Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2012 (2012), Article ID 347385, 11 pages
http://dx.doi.org/10.1155/2012/347385
Review Article

Ductal Carcinoma In Situ: Recent Advances and Future Prospects

1The Breast Unit, University Hospitals Leicester, Leicester LE3 9QP, UK
2The London Breast Institute, The Princess Grace Hospital, London W1U 5NY, UK

Received 3 December 2011; Accepted 22 February 2012

Academic Editor: Virgilio Sacchini

Copyright © 2012 Kelly Lambert et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Lippman, “Why study ductal carcinoma in-situ?” in Ductal Carcinoma In-situ of the Breast, M. J. Silverstein, A. Recht, and M. Lagios, Eds., pp. 12–16, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2nd edition, 2002. View at Google Scholar
  2. E. Netter, P. Troufleau, and J. Stines, “Ductal carcinoma in-situ of the breast: role of imaging,” Journal De Radiologie, vol. 79, no. 7, pp. 651–658, 1998. View at Google Scholar
  3. W. E. Sumner III, L. G. Koniaris, S. E. Snell et al., “Results of 23,810 cases of ductal carcinoma in-situ,” Annals of Surgical Oncology, vol. 14, no. 5, pp. 1638–1643, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. K. Bobo, N. C. Lee, and S. F. Thames, “Findings from 752081 clinical breast examinations reported to a national screening program from 1995 through 1998,” Journal of the National Cancer Institute, vol. 92, no. 12, pp. 971–976, 2000. View at Google Scholar · View at Scopus
  5. V. L. Ernster and J. Barclay, “Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma,” Journal of the National Cancer Institute. Monographs, no. 22, pp. 151–156, 1997. View at Google Scholar · View at Scopus
  6. B. A. Virnig, T. M. Tuttle, T. Shamliyan, and R. L. Kane, “Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes,” Journal of the National Cancer Institute, vol. 102, no. 3, pp. 170–178, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Sørum, S. Hofvind, P. Skaane, and T. Haldorsen, “Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme,” The Breast Journal, vol. 19, no. 6, pp. 499–505, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Pisano, C. Gatsonia, E. Hendrick et al., “Diagnostic performance of digital versus film mammography for breast-cancer screening,” The New England Journal of Medicine, vol. 353, no. 17, pp. 1773–1783, 2005. View at Publisher · View at Google Scholar
  9. C. Boetes and J. Veltman, “Screening women at increased risk with MRI,” International Cancer Imaging Society, vol. 5, no. A, pp. S10–S15, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. J. H. Menell, E. A. Morris, D. D. Dershaw, A. F. Abramson, E. Brogi, and L. Liberman, “Determination of the presence and extent of pure ductal carcinoma in-situ by mammography and magnetic resonance imaging,” The Breast Journal, vol. 11, no. 6, pp. 382–390, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Allegra, D. Aberle, P. Ganschow et al., “National institutes of health state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ september 22–24, 2009,” Journal of the National Cancer Institute, vol. 102, no. 3, pp. 161–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. C. K. Kuhl, S. Schrading, H. B. Bieling et al., “MRI for diagnosis of pure ductal carcinoma in-situ: a prospective observational study,” The Lancet, vol. 370, no. 9586, pp. 485–492, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. P. Schouten van der Velden, M. S. Schlooz-Vries, C. Boetes, and T. Wobbes, “Magnetic resonance imaging of ductal carcinoma in-situ: what is its clinical application? a review,” American Journal of Surgery, vol. 198, no. 2, pp. 262–269, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Warner, P. A. Causer, J. W. N. Wong et al., “Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study,” The Breast Journal, vol. 17, no. 1, pp. 9–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Mokbel, P. F. Escobar, and T. Matsunaga, “Mammary ductoscopy: current status and future prospects,” European Journal of Surgical Oncology, vol. 31, no. 1, pp. 3–8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. J. J. Going and D. F. Moffat, “Escaping from flatland: clinical and biological aspects of human mammary duct anatomy in three dimensions,” Journal of Pathology, vol. 203, no. 1, pp. 538–544, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Zhao, R. Freimanis, S. Bergman et al., “Biopsy needle technique and the accuracy of diagnosis of atypical ductal hyperplasia for mammographic abnormalities,” American Surgeon, vol. 69, no. 9, pp. 757–762, 2003. View at Google Scholar · View at Scopus
  18. S. Pinder, C. Duggan, I. Ellis et al., “A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial,” British Journal of Cancer, vol. 103, no. 1, pp. 94–100, 2010. View at Publisher · View at Google Scholar
  19. A. G. M. Douglas-Jones, J. M. Morgan, M. A. C. Appleton et al., “Consistency in the observation of features used to classify duct carcinoma in-situ (DCIS) of the breast,” Journal of Clinical Pathology, vol. 53, no. 8, pp. 596–602, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Bethwaite, N. Smith, B. Delahunt, and D. Kenwright, “Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast,” Journal of Clinical Pathology, vol. 51, no. 6, pp. 450–454, 1998. View at Google Scholar · View at Scopus
  21. I. O. Ellis, D. Coleman, C. Wells et al., “Impact of a national external quality assessment scheme for breast pathology in the UK,” Journal of Clinical Pathology, vol. 59, no. 2, pp. 138–145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. C. Lester, S. Bose, Y. Y. Chen, J. L. Connolly, M. E. De Baca, P. L. Fitzgibbons et al., “Protocol for the examination of specimens from patients with ductal carcinoma in-situ of the breast,” Archives of Pathology and Laboratory Medicine, vol. 133, no. 1, pp. 15–25, 2009. View at Google Scholar
  23. M. J. Silverstein, D. N. Poller, J. R. Waisman et al., “Prognostic classification of breast ductal carcinoma-in-situ,” The Lancet, vol. 345, no. 8958, pp. 1154–1157, 1995. View at Google Scholar · View at Scopus
  24. D. N. Poller, M. J. Silverstein, M. Galea et al., “Ideas in pathology. ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression,” Modern Pathology, vol. 7, no. 2, pp. 257–262, 1994. View at Google Scholar · View at Scopus
  25. W. L. Betsill, P. P. Rosen, P. H. Lieberman, and G. F. Robbins, “Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone,” Journal of the American Medical Association, vol. 239, no. 18, pp. 1863–1867, 1978. View at Publisher · View at Google Scholar · View at Scopus
  26. M. E. Sanders, P. A. Schuyler, W. D. Dupont, and D. L. Page, “The natural history of low-grade ductal carcinoma in-situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up,” Cancer, vol. 103, no. 12, pp. 2481–2484, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. G. D. Leonard and S. M. Swain, “Ductal carcinoma in-situ, complexities and challenges,” Journal of the National Cancer Institute, vol. 96, no. 12, pp. 906–920, 2004. View at Google Scholar · View at Scopus
  28. K. Kerlikowske, A. Molinaro, I. Cha et al., “Characteristics associated with recurrence among women with ductal carcinoma in-situ treated by lumpectomy,” Journal of the National Cancer Institute, vol. 95, no. 22, pp. 1692–1702, 2003. View at Google Scholar · View at Scopus
  29. N. Bijker, J. L. Peterse, L. Duchateau et al., “Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma in-situ: analysis of european organization for research and treatment of cancer trial 10853,” Journal of Clinical Oncology, vol. 19, no. 8, pp. 2263–2271, 2001. View at Google Scholar · View at Scopus
  30. F. Nakhlis and M. Morrow, “Ductal carcinoma in-situ,” Surgical Clinics of North America, vol. 83, no. 4, pp. 821–839, 2003. View at Google Scholar · View at Scopus
  31. M. A. Ben-David, D. E. Sturtz, K. A. Griffith et al., “Long-term results of conservative surgery and radiotherapy for ductal carcinoma in-situ using lung density correction: the University of Michigan experience,” The Breast Journal, vol. 13, no. 4, pp. 392–400, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Di Saverio, F. Catena, D. Santini et al., “259 patients with DCIS of the breast applying USC/van nuys prognostic index: a retrospective review with long term follow up,” Breast Cancer Research and Treatment, vol. 109, no. 3, pp. 405–416, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. F. A. Vicini and A. Recht, “Age at diagnosis and outcome for women with ductal carcinoma in-situ of the breast: a critical review of the literature,” Journal of Clinical Oncology, vol. 20, no. 11, pp. 2736–2744, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Y. Wang, T. Shamliyan, B. A. Virnig, and R. Kane, “Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis,” Breast Cancer Research and Treatment, vol. 127, no. 1, pp. 1–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Fisher, S. Land, E. Mamounas, J. Dignam, E. R. Fisher, and N. Wolmark, “Prevention of invasive breast cancer in women with ductal carcinoma in-situ: an update of the national surgical adjuvant breast and bowel project experience,” Seminars in Oncology, vol. 28, no. 4, pp. 400–418, 2001. View at Google Scholar · View at Scopus
  36. G. F. Schwartz, L. J. Solin, I. A. Olivotto et al., “Consensus Conference on the treatment of in situ Ductal Carcinoma of the breast, April 22-25,1999,” Cancer, vol. 88, no. 4, pp. 946–954, 2000. View at Publisher · View at Google Scholar
  37. B. Cutuli, C. Cohen-Solal-le Nir, B. De Lafontan et al., “Breast conserving therapy for ductal carcinoma in-situ of the breast: the French Cancer Centers' experience,” International Journal of Radiation Oncology Biology Physics, vol. 53, no. 4, pp. 868–879, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Cutuli, C. Lemanski, M. Le Blanc et al., “Local recurrences after DCIS therapy: diagnosis, treatment and outcome,” Breast Cancer Research and Treatment, vol. 76, supplement 1, article A31, p. 36, 2002. View at Google Scholar
  39. H. R. MacDonald, M. J. Silverstein, H. Mabry et al., “Local control in ductal carcinoma in-situ treated by excision alone: incremental benefit of larger margins,” American Journal of Surgery, vol. 190, no. 4, pp. 521–525, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. A. C. Neuschatz, T. DiPetrillo, M. Steinhoff et al., “The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in-situ of the breast,” Cancer, vol. 94, no. 7, pp. 1917–1924, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. B Cutuli, A Fourquet , E Luporsi et al., “Standards, Options et Recommendations 2004. Prise en charge des carcinomes canalaires in-situ du sein,” Bulletin du Cancer, vol. 92, no. 2, pp. 155–168, 2005. View at Google Scholar
  42. C. Dunne, J. P. Burke, M. Morrow, and M. R. Kell, “Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ,” Journal of Clinical Oncology, vol. 27, no. 10, pp. 1615–1620, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Park and J. Schmitt, “Joint center for radiation therapy experience,” in Ductal Carcinoma in-situ of the Breast, M. J. Silverstein, A. Recht, and M. Lagios, Eds., pp. 373–380, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2nd edition, 2002. View at Google Scholar
  44. L. S. Phillips, R. C. Millikan, J. C. Schroeder, J. S. Barnholtz-Sloan, and B. J. Levine, “Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 5, pp. 1507–1514, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. M. J. Silverstein, “The University of Southern California/Van Nuys prognostic index for ductal carcinoma in-situ of the breast,” American Journal of Surgery, vol. 186, no. 4, pp. 337–343, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. M. J. Silverstein, “An argument against routine use of radiotherapy for ductal carcinoma in-situ,” Oncology, vol. 17, no. 11, pp. 1511–1533, 2003. View at Google Scholar · View at Scopus
  47. T. Baqai and S. Shousha, “Oestrogen receptor negativity as a marker for high-grade ductal carcinoma in situ of the breast,” Histopathology, vol. 42, no. 5, pp. 440–447, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. E. Provenzano, J. L. Hopper, G. G. Giles, G. Marr, D. J. Venter, and J. E. Armes, “Biological markers that predict clinical recurrence in ductal carcinoma in-situ of the breast,” European Journal of Cancer, vol. 39, no. 5, pp. 622–630, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. R. E. Roses, E. C. Paulson, A. Sharma et al., “Her-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 5, pp. 1385–1389, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Sorlie, C. M. Perou, R. Tibshirani et al., “Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 19, pp. 10869–10874, 2001. View at Google Scholar
  51. S. Clark, J. Warwick, R. Carpenter, R. L. Bowen, S. W. Duffy, and J. L. Jones, “Molecular subtyping of dcis: heterogeneity of breast cancer reflected in pre-invasive disease,” British Journal of Cancer, vol. 104, no. 1, pp. 120–127, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Buerger, F. Otterbach, R. Simon et al., “Comparative genomic hybridization of ductal carcinoma in-situ of the breast—evidence of multiple genetic pathways,” Journal of Pathology, vol. 187, no. 4, pp. 396–402, 1999. View at Publisher · View at Google Scholar
  53. M. Aubele, A. Mattis, H. Zitzelsberger et al., “Extensive ductal carcinoma in-situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH,” International Journal of Cancer, vol. 85, no. 1, pp. 82–86, 2000. View at Google Scholar
  54. J. Hannemann, A. Velds, J. B. G. Halfwerk, B. Kreike, J. L. Peterse, and M. J. Van de Vijver, “Classification of ductal carcinoma in-situ by gene expression profiling,” Breast Cancer Research, vol. 8, no. 5, article R61, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. R. L. Balleine, L. R. Webster, S. Davis et al., “Molecular grading of ductal carcinoma in situ of the breast,” Clinical Cancer Research, vol. 14, no. 24, pp. 8244–8252, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. J. D. Wulfkuhle, D. C. Sgroi, H. Krutzsch et al., “Proteomics of human breast ductal carcinoma in-situ,” Cancer Research, vol. 62, no. 22, pp. 6740–6749, 2002. View at Google Scholar · View at Scopus
  57. M. Gotte, C. Kersting, I. Radke, L. Kiesel, and P. Wulfing, “An expression signature of syndecan-1 (cd138), e-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in-situ,” Breast Cancer Research, vol. 9, no. 1, article R8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. L. O. Gonzalez, S. Junquera, J. M. del Casar et al., “Immunohistochemical study of matrix metalloproteinases and their inhibitors in pure and mixed invasive and in situ ductal carcinomas of the breast,” Human Pathology, vol. 41, no. 7, pp. 980–989, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Morrow, E. A. Strom, L. W. Bassett et al., “Standard for the management of ductal carcinoma in-situ of the breast (DCIS),” CA: A Cancer Journal for Clinicians, vol. 52, no. 5, pp. 256–276, 2002. View at Google Scholar · View at Scopus
  60. J. Boyages, G. Delaney, and R. Taylor, “Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis,” Cancer, vol. 85, no. 3, pp. 616–628, 1999. View at Publisher · View at Google Scholar
  61. M. Douek and M. Baum, “Mass breast screening: is there a hidden cost?” The British Journal of Surgery, vol. 90, supplement 1, article 14, pp. 44–45, 2003. View at Google Scholar
  62. B. Cutuli, C. Lemanski, A. Fourquet et al., “Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience,” British Journal of Cancer, vol. 100, no. 7, pp. 1048–1054, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. G. H. Cunnick and K. Mokbel, “Skin-sparing mastectomy,” American Journal of Surgery, vol. 188, no. 1, pp. 78–84, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. G. L. Ottesen, H. P. Graversen, M. Blichert-Toft, I. J. Christensen, and J. A. Andersen, “Carcinoma in-situ of the female breast. 10-year follow-up results of a prospective nation-wide study,” Breast Cancer Research and Treatment, vol. 62, no. 3, pp. 197–210, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Ringberg, I. Idvall, M. Ferno et al., “Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in-situ of the breast,” European Journal of Surgical Oncology, vol. 26, no. 5, pp. 444–451, 2000. View at Publisher · View at Google Scholar · View at Scopus
  66. L. Cataliotti, V. Distante, L. Orzalesi et al., “The florence experience,” in Ductal Carcinoma In-situ of the Breast, M. J. Silverstein, A. Recht, and M. Lagios, Eds., pp. 348–353, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2nd edition, 2002. View at Google Scholar
  67. C. Tunon De Lara, I. De Mascarel, G. Mac Grogan et al., “Analysis of 676 cases of ductal carcinoma in-situ (DCIS) of the breast from 1971 to 1995: diagnosis and treatment: the experience of one institute,” American Journal of Clinical Oncology, vol. 24, no. 6, pp. 531–536, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. G. F. Schwartz, “Treatment of subclinical ductal carcinoma in-situ of the breast by local excision and surveillance: an update personal experience,” in Ductal Carcinoma In-Situ of the Breast, M. J. Silverstein, A. Recht, and M. Lagios, Eds., pp. 308–321, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2nd edition, 2002. View at Google Scholar
  69. M. D. Lagios and M. J. Silverstein, “Ductal carcinoma in-situ: the success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies,” Surgical Oncology Clinics of North America, vol. 6, no. 2, pp. 385–392, 1997. View at Google Scholar · View at Scopus
  70. L. G. Arnesson and K. Olsen, “Linköping experience,” in Ductal Carcinoma In-Situ of the Breast, M. J. Silverstein, Ed., pp. 373–377, Williams & Wilkins, Baltimore, Md, USA, 1997. View at Google Scholar
  71. L. J. Solin, A. Fourquet, F. A. Vicini et al., “Long-term outcome after breast conservation treatment with radiation for mammographically detected ductal carcinoma in-situ of the breast,” Cancer, vol. 103, no. 6, pp. 1137–1146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. L. J. Solin, A. Fourquet, F. A. Vicini et al., “Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in-situ,” European Journal of Cancer, vol. 41, no. 12, pp. 1715–1723, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. I. L. Wapnir, J. J. Dignam, B. Fisher et al., “Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS,” Journal of the National Cancer Institute, vol. 103, no. 6, pp. 478–488, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. N. Bijker, P. H. Meijnen, J. Bogaerts et al., “Radiotherapy in breast conserving treatment for ductal carcinoma in-situ (DCIS): ten year results of European organization for research and treatment of cancer (EORTC) randomized trial 10853,” Breast Cancer Research and Treatment, vol. 94, supplement 1, article A7, 2005. View at Google Scholar
  75. J. Houghton, W. D. George, J. Cuzick et al., “Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in-situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial,” The Lancet, vol. 362, no. 9378, pp. 95–102, 2003. View at Google Scholar
  76. J. Cuzick, I. Sestak, S. Pinder et al., “Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial,” The Lancet Oncology, vol. 12, no. 1, pp. 21–29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. S. O. Emdin, B. Granstrand, A. Ringberg, K. Sandelin et al., “SweDCIS: radiotherapy after sector resection for ductal carcinoma in-situ of the breast. Results of a randomised trial in a population offered mammography screening,” Acta Oncologica, vol. 45, no. 5, pp. 536–543, 2006. View at Publisher · View at Google Scholar
  78. A. Goodwin, S. Parker, D. Ghersi, and N. Wilcken, “Post-operative radiotherapy for ductal carcinoma in situ of the breast,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD000563, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. G. A. Viani, E. J. Stefano, S. L. Afonso et al., “Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials,” Radiation Oncology, vol. 2, no. 1, article 28, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. B. Fowble, “Overview of conservative surgery and radiation therapy: ductal carcinoma in-situ,” in Ductal Carcinoma In-situ of the Breast, M. J. Silverstein, A. Recht, and M. Lagios, Eds., pp. 287–302, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2nd edition, 2002. View at Google Scholar
  81. O. Abe, R. Abe, K. Asaishi et al., “Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials,” The New England Journal of Medicine, vol. 333, no. 22, pp. 1444–1455, 1995. View at Publisher · View at Google Scholar
  82. M. Overgaard, P. S. Hansen, J. Overgaard et al., “Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial,” The New England Journal of Medicine, vol. 337, no. 14, pp. 949–955, 1997. View at Google Scholar
  83. M. Overgaard, M. B. Jensen, J. Overgaard et al., “Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: danish breast-cancer cooperative group DBCG 82c randomised trial,” The Lancet, vol. 353, no. 9165, pp. 1641–1648, 1999. View at Publisher · View at Google Scholar · View at Scopus
  84. R. Yerushalmi, A. Sulkes, M. Mishaeli et al., “Radiation treatment for ductal carcinoma in-situ (DCIS): is a boost to the tumor bed necessary?” Neoplasma, vol. 53, no. 6, pp. 507–510, 2006. View at Google Scholar · View at Scopus
  85. J. S. Vaidya, “Partial breast irradiation using targeted intraoperative radiotherapy (Targit),” Nature Clinical Practice Oncology, vol. 4, no. 7, pp. 384–385, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. F. Vicini, P. D. Beitsch, C. A. Quiet et al., “Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American society of breast surgeons mammosite breast brachytherapy registry trial in patients treated with accelerated partial breast irradiation (APBI),” Cancer, vol. 112, no. 4, pp. 758–766, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. P. Z. Israel, F. Vicini, A. B. Robbins et al., “Ductal carcinoma in situ of the breast treated with accelerated partial breast irradiation using balloon-based brachytherapy,” Annals of Surgical Oncology, vol. 17, no. 11, pp. 2940–2944, 2010. View at Publisher · View at Google Scholar
  88. L. L. Hughes, M. Wang, D. L. Page et al., “Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the eastern cooperative oncology group,” Journal of Clinical Oncology, vol. 27, no. 32, pp. 5319–5324, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. S. B. Motwani, S. Goyal, M. S. Moran, A. Chhabra, and B. G. Haffty, “Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194,” Cancer, vol. 117, no. 6, pp. 1156–1162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. B. Fisher, J. Dignam, N. Wolmark et al., “Tamoxifen in treatment of intraductal breast cancer: national surgical adjuvant breast and bowel project B-24 randomised controlled trial,” The Lancet, vol. 353, no. 9169, pp. 1993–2000, 1999. View at Publisher · View at Google Scholar · View at Scopus
  91. B. Fisher, S. Land, E. Mamounas et al., “Prevention of invasive breast cancer in women with ductal carcinoma in-situ: an update of the national surgical adjuvant breast and bowel project experience,” in Ductal Carcinoma In-situ of the Breast, M. J. Silverstein, A. Recht, and M. Lagios, Eds., pp. 432–446, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2nd edition, 2002. View at Google Scholar
  92. D. C. Allred, J. Bryant, S. Lano et al., “Estrogen receptor expression as a predictive marker of the effectiveness of tamoxifen in the treatment of DCIS: findings from NSABP protocol B-24,” Breast Cancer Research and Treatment, vol. 76, supplement 1, article A30, p. 536, 2002. View at Google Scholar
  93. M. Hu, G. Peluffo, H. Chen, R. Gelman, S. Schnitt, and K. Polyak, “Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 9, pp. 3372–3377, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. S. J. Schnitt, “The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin,” Breast Cancer Research, vol. 11, no. 1, article 101, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. N. J. Bundred, A. Cramer, J. Morris et al., “Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the erisac randomized placebo-controlled trial,” Clinical Cancer Research, vol. 16, no. 5, pp. 1605–1612, 2010. View at Publisher · View at Google Scholar · View at Scopus
  96. T. W. F. Yen, K. K. Hunt, M. I. Ross et al., “Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in-situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ,” Journal of the American College of Surgeons, vol. 200, no. 4, pp. 516–526, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. M. Dillon, E. McDermott, C. Quinn, A. O'Doherty, N. O'Higgins, and A. Hill, “Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only,” Journal of Surgical Oncology, vol. 93, no. 7, pp. 559–563, 2006. View at Publisher · View at Google Scholar · View at Scopus
  98. P. Veronesi, M. Intra, A. R. Vento et al., “Sentinel lymph node biopsy for localised ductal carcinoma in-situ?” The Breast Journal, vol. 14, no. 6, pp. 520–522, 2005. View at Publisher · View at Google Scholar · View at Scopus
  99. T. B. Julian, S. R. Land, V. Fourchotte et al., “Is sentinel node biopsy necessary in conservatively treated DCIS?” Annals of Surgical Oncology, vol. 14, no. 8, pp. 2202–2208, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. J. L. Warren, D. L. Weaver, T. Bocklage et al., “The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS. A population-based analysis,” Cancer, vol. 104, pp. 1840–1848, 2005. View at Google Scholar
  101. M. J. Silverstein, M. D. Lagios, S. Martino et al., “Outcome after invasive local recurrence in patients with ductal carcinoma in-situ of the breast,” Journal of Clinical Oncology, vol. 16, no. 4, pp. 1367–1373, 1998. View at Google Scholar · View at Scopus
  102. B. Cutuli, C. Borel, F. Dhermain et al., “Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases,” Radiotherapy and Oncology, vol. 59, no. 3, pp. 247–255, 2001. View at Publisher · View at Google Scholar · View at Scopus
  103. B. Cutuli, J. M. Dilhuydy, B. De Lafontan et al., “Ductal carcinoma in-situ of the male breast: analysis of 31 cases,” European Journal of Cancer A, vol. 33, no. 1, pp. 35–38, 1997. View at Publisher · View at Google Scholar · View at Scopus
  104. A. P. Hittmair, R. A. Lininger, and F. A. Tavassoli, “Ductal carcinoma in-situ (DCIS) in the male breast: a morphologic study of 84 cases of pure DCIS and 30 cases of DCIS associated with invasive carcinoma: a preliminary report,” Cancer, vol. 83, no. 10, pp. 2139–2149, 1998. View at Publisher · View at Google Scholar
  105. J. F. Head and R. L. Elliott, “Stereotactic radiofrequency ablation: a minimally invasive technique for nonpalpable breast cancer in postmenopausal patients,” Cancer Epidemiology, vol. 33, no. 3-4, pp. 300–305, 2009. View at Publisher · View at Google Scholar · View at Scopus